UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	April 19, 2022

Accession Number:	0001628280-22-009319
Submission Type:	POS AM
CIK: 0001822462 Company Name: Foghorn Therapeutics Inc. File Number: 333-262711